{"title":"在同种异体干细胞移植后巨细胞病毒感染患者中,Foscarnet与更昔洛韦同样有效地预防巨细胞病毒病","authors":"Nina Singh","doi":"10.1054/EBON.2002.0038","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"15 1","pages":"128-130"},"PeriodicalIF":0.0000,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Foscarnet is as effective as ganciclovir for preventing cytomegalovirus disease in people with cytomegalovirus infection after allogeneic stem cell transplantation\",\"authors\":\"Nina Singh\",\"doi\":\"10.1054/EBON.2002.0038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100515,\"journal\":{\"name\":\"Evidence-based Oncology\",\"volume\":\"15 1\",\"pages\":\"128-130\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-based Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1054/EBON.2002.0038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1054/EBON.2002.0038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Foscarnet is as effective as ganciclovir for preventing cytomegalovirus disease in people with cytomegalovirus infection after allogeneic stem cell transplantation